VERBINDUNGEN

European patent · EP3331885 · In force

Register entry

Publication number
EP3331885
Application number
EP16747519
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 3, 2016
Published
Jun 13, 2018
Granted
Dec 23, 2020
Protection ends at the latest
Aug 2, 2036
Next annual fee due
Aug 31, 2027
IPC classes
C07D 487/04 (2006.01)
A61K 31/52 (2006.01)
A61K 31/53 (2006.01)
A61P 33/02 (2006.01)
A61K 31/519 (2006.01)
A61K 31/5377 (2006.01)
A61K 31/553 (2006.01)
A61P 33/14 (2006.01)
Priority
EP 15382418 07.08.2015
PCT application
PCT/EP2016/068592 03.08.2016
PCT publication
WO2017/025416 16.02.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Dec 16, 2025

    Corrected

    Owner
    GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom → GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom, University Of Dundee, Nethergate, Dundee DD1 4HN, United Kingdom

    Published in Swissreg on 16.12.2025

  3. Nov 7, 2025

    Holder’s address changed

    Owner
    GlaxoSmithKline Intellectual Property Development, Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom, University Of Dundee, Nethergate, Dundee DD1 4HN, United Kingdom → GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom

    Published in Swissreg on 07.11.2025

  4. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  5. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  6. Dec 20, 2023

    Address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 20.12.2023

  7. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  8. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

3 earlier entries
  1. Nov 3, 2021

    Change

    Published in Swissreg on 03.11.2021

  2. Feb 19, 2021

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 19.02.2021

  3. Dec 23, 2020

    Granted

    Published in Swissreg on 23.12.2020

Parties

Holder

GlaxoSmithKline Intellectual Property Development Limited

GSK Medicines Research Centre Gunnels Wood Road, Stevenage, SG1 2NY, GB

University of Dundee

University Of Dundee

Nethergate, Dundee DD1 4HN, GB

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

DODD, PeterGeorge

Dundee Tayside DD1 5EH, GB

SANDBERG, Lars Henrik

Dundee Tayside DD1 5EH, GB

MARCO MARTIN, Maria

28760 Tres Cantos (Madrid), ES

KO, Eun Jung

Dundee Tayside DD1 5EH, GB

THOMPSON, Stephen

Dundee Tayside DD1 5EH, GB

MILES, Timothy James

28760 Tres Cantos (Madrid), ES

BRAND, Stephen

Dundee Tayside DD1 5EH, GB

THOMAS, Michael George

Dundee Tayside DD1 5EH, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.